Japan Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Japan Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Japan Cell and Gene Therapy Manufacturing QC Market was valued at USD 136.58 Million in 2024 and is projected to reach USD 348.18 Million by 2028, expanding at a CAGR of 26.4% during the forecast period. This growth is primarily driven by increasing applications in pharmaceutical and healthcare industries, intensified by Japan's robust focus on biotechnology. Key trends include green processing and low-carbon production lines, followed by technological advancements in cell and gene therapy manufacture. The market's growth is expected to be further propelled by unique opportunities in agricultural and energy sectors, as these fields increasingly explore biotechnologies. Japan is positioning itself as a leader in the field, enhancing its export potential while ensuring domestic demands are met. Sustainable, forward-thinking strategies are projected to maintain the Japan cell and gene therapy manufacturing QC market's significant growth in the coming years.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market Highlights
- By 2024, Cell Therapy represented the largest share of the Therapy Type market size.
- Gene Therapy is expected to remain the key growth driver within Therapy Type, registering the fastest CAGR during the forecast period.
- Japan contributed 6.11% to the global cell and gene therapy manufacturing qc market size in 2024.
- By 2028, United States is forecasted to remain the largest global market for cell and gene therapy manufacturing qc market.
- In Asia Pacific, China is projected to capture the leading share of market by 2028.
- Among Asia Pacific markets, India is expected to post the fastest growth, reaching USD 58503 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 136.58 Million |
| Market Size In 2028 | USD 348.18 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 26.4% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Japan Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Japan Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Japan Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
